Publication

Mouse models of nonalcoholic steatohepatitis in preclinical drug development

Drug Discovery Today 22(11):1707–1718, 2017

Hansen HH, Feigh M, Veidal SS, Rigbolt KT, Vrang N, Fosgerau K.

Share this page

Resource Library

Related resources

Molecular characterization of microvesicular and macrovesicular steatosis shows widespread differences in metabolic pathways

Metabolic, biochemical, histopathological, and transcriptomic effects of dietary intervention in the GAN diet-induced obese and biopsy-confirmed mouse model of NASH

Preclinical efficacy and clinical translatability of obeticholic acid in the GAN diet-induced obese and biopsy-confirmed mouse model of NASH

Hepatic immune cell profiling of the GAN diet-induced obese and biopsy-confirmed mouse model of NASH with advanced fibrosis and HCC

For further information

Contact us

Gubra

Hørsholm Kongevej 11B
2970 Hørsholm
Denmark

+45 3152 2650